Faculty: Charles Nottingham, MD and Alexis TE, MD

Moderator: Steven Kaplan, MD


Charles Nottingham, MD

Dr. Charles Nottingham is an endourologist at Washington University in St Louis specializing in surgical treatment of BPH and stone disease. He completed endourology fellowship at Indiana University Methodist Hospital in 2020 with Drs. Amy Krambeck and Jim Lingeman. He completed urology residency at the University of Chicago in 2018.

Alexis TE, MD

Dr. Alexis E. Te is a Professor of Urology at the Weill Medical College at Cornell University and Director of the Brady Prostate Center and the Urology Program of the Iris Cantor Men’s Health Center in Department of Urology at New York Presbyterian Hospital. Dr. Te graduated from Yale University and received his medical degree from Cornell University Medical College. He completed his urology residency and fellowship in Neurourology and Urodynamics at the College of Physicians and Surgeons of Columbia University.  
Dr. Te is a national and international key opinion leader on minimally invasive BPH therapies including using the 532 nm wavelength or Greenlight Laser for benign prostate surgery, and is active in numerous clinical trials for BPH therapies. Dr. Te is active lecturer and clinician, honored annually as a top clinician in Castle Connelly, Best Doctors and Superdocs. He is also active reviewer and has been on editorial board of numerous journals, and has over 300 publications. Dr. Te’s main areas of academic interest and research include Prostate Disease including BPH, chronic prostatitis and prostate cancer as well as voiding dysfunction, urodynamics, neurourology, incontinence and female urology. As an innovator in medical technology, Dr. Te has patents in medical applications. 

Steven Kaplan, MD

elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital as well as a residency in Urology at the Squier Urologic Clinic, Columbia University. He was an American Urologic Association Scholar between 1988 – 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction. Dr. Kaplan was the Given Foundation Professor of Urology and Administrator, as well as Vice Chairman of the Department of Urology at Columbia University from 1998 – 2005. And then, the E Darracott Vaughan Jr. Professor of Urology and Chief, Institute for Bladder and Prostate Health at Weill Cornell Medical College and Director, Iris Cantor Men’s Health Center at New York Presbyterian Hospital. Currently, he is Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of Benign Urologic Diseases and The Men’s Health Program of the Mount Sinai Health System. He is a serial entrepreneur and a founder of Medidata Solutions Inc., a publicly held corporation and one of the premier electronic data capture companies in the world; Medivizor, Inc., a medical informatics enterprise; Eco – Fusion, a novel health care interface platform and InspiReN, a digital interface analyzing and enhancing the patient experience with health care professionals. Dr. Kaplan is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He is a recognized authority on the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has published more than 1200 articles, 170 abstracts, and has made over 340 presentations in more than 35 countries. He is the co - author of five books and is on the Editorial Board of Urology, Journal of Urology, and Urology Times. Dr. Kaplan has been a member of more than 30 professional organizations, been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation. Most recently, he serves on the AUA BPH Guidelines Committee and is the Chair – Elect of AUA Research.